Lewis EJ, Hunsicker LG, Bain RP, Rohde RDThe effect of angiotensin-converting enzyme inhibition on diabetic nephropathy . N Engl J Med1993;329:1456-62.
2.
Kasiske BL, Kalil RSN, Ma JZ, Liao M., Keane WFEffect of therapy on the kidney in patients with diabetes:A meta-regression analysis. Ann Intern Med1993;118:129-38.
3.
Hollenberg NK , Raij L.Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy. Arch Intern Med1993;153:2426-35.
4.
Ichikawa I.Will Ang II receptor antagonists be renoprotective in humans?Kidney Intern1996;50:684-92.
5.
Hollenberg NKACE inhibitors,AT1-receptor blockers, and the kidney. E Ritz (Ed) Nephrol Dial Transplant1997;12: 381-3.
6.
Hollenberg NK , Fisher NKRenal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word?Hypertension1995;26: 602-9.
7.
Roman RJ, Kaldunski ML, Scicli AG, Carretero OAInfluence of kinins and angiotensin II on the regulation of papillary blood flow. Am J Physiol1988;255:F690-F698.
8.
Price DA, De'Oliveira JM, Fisher NDL, Hollenberg NKRenal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men. Hypertension1997;39:240-6.
9.
Price DA, Porter LE, Gordon M. et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol1999;10:2382-91.
10.
Christlieb AR, KaldanyA,D'Elia JAPlasma renin activity and hypertension in diabetes mellitus. Diabetes1976;25:969-74.
11.
Bjorck S.The renin-angiotensin system in diabetes mellitus: a physiological and therapeutic study. Scand J Urol Nephrol Suppl1990;126:1-50.
12.
Lush DJ, King JA, Fray JCS.Pathophysiology of low renin syndromes: sites of renal renin secretory impairment and prorenin overexpression. Kidney Int1993 ;43:983-99.
13.
Weidmann P., Ferrari P., Shaw SGRenin in Diabetes Mellitus. In: JIS Robertson and MG Nicholls (Ed). The Renin-Angiotensin System. New York: Raven Press, 1991; Chapter 75; 75.1-75.26.
14.
Rosenberg ME , Smith LJ, Correa-Rotter R., Hostetter THThe paradox of the renin-angiotensin system in chronic renal disease. Kidney Int1994;45:403-10.
15.
Kikkawa R., Kitamura E., Fujiwara Y., Haneda M., Shigeta Y.Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Renal Physiol1986;9: 187-92.
16.
Anderson S. , Jung FF, Ingelfinger JRRenal renin-angiotensin system in diabetes: functional immunohistochemical, and molecular biological correlations . Am J Physiol1993;265:F477-F486.
17.
De'Oliveira JM, Price DA, Fisher NDL et al. Autonomy of the renin system in type II diabetes mellitus: Dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney International1997;52:771-7.
18.
Miller JA, Floras JS, Zinman B., Skorecki KL, Logan AGEffect of hyperglycemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci1996;90:189-95.
19.
Osei SY, Price DA, Fisher NDL, Porter LE, Laffel LMB, Hollenberg NKHyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans. Hypertension1999;3:559-64.
20.
Osei SY, Price DA, Laffel LMB, Lansang MC, Hollenberg NKEffect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans. Hypertension2000;36:122-6.
